Designing Personalized Vaccines
[intense_content_section imagemode="fixed" speed="2" margin_bottom="5px" padding_top="" padding_bottom="5px" advance_arrow_position="50" tab_28000="" tab_537="" tab_13022="" tab_31935="" tab_32652="" tab_9941="" tab_7914="" tab_9691="" tab_2168="" tab_23789="" tab_30498="" tab_17843="" tab_26480=""
[intense_content_section imagemode="fixed" speed="2" margin_bottom="5px" padding_top="" padding_bottom="5px" advance_arrow_position="50" tab_28000="" tab_537="" tab_13022="" tab_31935="" tab_32652="" tab_9941="" tab_7914="" tab_9691="" tab_2168="" tab_23789="" tab_30498="" tab_17843="" tab_26480=""
Location: United States, California, Irvine
Employees: 11-50
Total raised: $31.2M
Founded date: 2016
Investors 1
| Date | Name | Website |
| - | Ci:z Inves... | cizinvestm... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 25.02.2020 | Series B | $12.5M | - |
| 18.07.2018 | Grant | $1.7M | - |
| 12.06.2018 | Series B | $15M | - |
| 11.06.2016 | Series A | $2M | - |
Mentions in press and media 13
| Date | Title | Description |
| 13.01.2021 | Biotech startup raises $25M for cancer, Covid-19 vaccines | Promoted Clinical Care Capacity Planning Learn how to manage clinical care capacity more efficiently during uncertain times. SAP Promoted This Patient Experience Checklist Is Your Key To Success in 2021 As healthcare systems strive to recov... |
| 05.01.2021 | AIVITA Biomedical Closes $25M Series B-2 Round | IRVINE, CA, AIVITA Biomedical has closed its Series B-2 financing round for up to $25 million. >> Click here for more funding data on AIVITA Biomedical >> To export AIVITA Biomedical funding data to PDF and Excel, click here... |
| 05.01.2021 | Daily funding roundup - January 4th, 2021 | Oxygen has raised $17M; Aivita Biomedical landed $25M; AMP Robotics secured $55M; Kong got $93M Oxygen: Oxygen is a San Francisco-based digital banking startup. Oxygen has raised $17 million in Series A funding, including from Runa Capital,... |
| 29.12.2020 | AIVITA Biomedical Closes $25 Million Financing Round | |
| 25.02.2020 | Aivita Biomedical Raises $12.5M in Series B-2 Financing | Aivita Biomedical, Inc., an Irvine, Calif.-based biotechnology company specializing in innovative stem cell applications, held the first closing of its $25m Series B-2 funding. The first closing of $12.5m was led by Matthew Katz, founder an... |
| 18.07.2018 | Aivita Biomedical Receives $1.7M Grant to Treat Vision Loss | Aivita Biomedical, an Irvine, CA-based biotech company specializing in innovative stem cell applications, received $1.7m in funding. The California Institute for Regenerative Medicine (CIRM) has provided the award. The company intends to us... |
| 12.06.2018 | Aivita Biomedical Raises $15M in Series B Financing | Aivita Biomedical, an Irvine, Calif.-based global biotech specializing in innovative stem cell applications, raised $15m in a Series B financing. The financing was provided by SFC Co. Ltd., a South Korean investor that is listed on the KOSD... |
| 13.06.2016 | AiVita Biomedical Raises $2M in Series A | IRVINE, CA, Therapeutic development company focused on regenerative and curative medicines, today announced it has completed a $2 million Series A round of equity investment. >> Click here for more funding data on AiVita Biomedical... |
| 13.06.2016 | AiVita raises $2M for ovarian cancer immunotherapy treatment | AiVita is also investigating a treatment for age-related macular degeneration (AMD), using pluripotent stem cells to create retinal tissue. There are no effective therapies for dry AMD. VEGF inhibitors can limit the blood vessel growth asso... |
| 13.06.2016 | AiVita Biomedical Gets $2M | Irvine-based AiVita Biomedical, a biopharmaceuticals company focused on regenerative medicine, has raised $2M in a Series A financing. The funding came from California Technology Ventures. As part of the funding, Alex Suh of CTV will join t... |
Show more